Benzylhydrochlorothiazide D5
| Product Name | Benzylhydrochlorothiazide D5 |
|---|---|
| Alternate Names | Hydrochlorothiazide Stable Isotopes, Stable Isotopes of Hydrochlorothiazide |
| CAT No. | CS-CX-00169 |
| CAS No. | 1185024-05-8 |
| Category | Stable Isotopes |
| Stock | Enquire |
| Mol. Wt. | Not Available |
| Mol. For. | Not Available |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Hydrochlorothiazide |
| Smileys | C1=CC=C(C=C1)CC2NC3=CC(=C(C=C3S(=O)(=O)N2)S(=O)(=O)N)Cl |
| Canonical Smiles | C1=CC=C(C=C1)CC2NC3=CC(=C(C=C3S(=O)(=O)N2)S(=O)(=O)N)Cl |
| InchIKey | BWSSMIJUDVUASQ-RALIUCGRSA-N |
| Inchl | InChI=1S/C14H14ClN3O4S2/c15-10-7-11-13(8-12(10)23(16,19)20)24(21,22)18-14(17-11)6-9-4-2-1-3-5-9/h1-5,7-8,14,17-18H,6H2,(H2,16,19,20)/i1D,2D,3D,4D,5D |
| IUPAC | 6-chloro-1,1-dioxo-3-[(2,3,4,5,6-pentadeuteriophenyl)methyl]-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Benzylhydrochlorothiazide D5 is a deuterated form of Benzylhydrochlorothiazide, a medication used to treat hypertension and edema. This medication works by decreasing the amount of water and salt in the body, which helps to lower blood pressure and reduce swelling.
Chemically, Benzylhydrochlorothiazide D5 is a thiazide diuretic, which means it works by inhibiting the reabsorption of sodium and chloride ions in the kidneys. This leads to increased excretion of water and electrolytes in the urine, resulting in decreased blood volume and lowered blood pressure.
Benzylhydrochlorothiazide D5 is available in tablet form and is typically taken once daily in the morning. The dosage is determined by the severity of the condition being treated and the patient's response to the medication.
It is important to note that Benzylhydrochlorothiazide D5 may interact with other medications, including lithium, digoxin, and nonsteroidal anti-inflammatory drugs (NSAIDs). Patients should inform their healthcare provider of all medications they are currently taking before starting treatment with Benzylhydrochlorothiazide D5.
Common side effects of this medication include dizziness, headache, nausea, and increased urination. If any of these side effects persist or worsen, patients should contact their healthcare provider. In rare cases, Benzylhydrochlorothiazide D5 may cause more serious side effects such as liver or kidney damage. Patients should report any unusual symptoms to their healthcare provider immediately.
Get an Instant Quote
Related Compounds
Hydrochlorothiazide-13CD6 | Hydrochlorothiazide 15N2 13C D2 | Hydrochlorothiazide D2 | Hydrochlorothiazide 13C D2 | Hydrochlorothiazide 13C6 |